Some of the nation's largest drug makers will no longer sell cold medicines targeted at infants due to safety concerns. Full Article at N.J. Courier-Post Online

Safety concerns involving overdoses prompted leading manufacturers to halt sales of over-the-counter infant cold and cough medicines, the companies announced yesterday. Full Article at Washington Times

Rise and shine, oh ye weary, sleep-deprived parents. Your lives just got a little tougher. Full Article at Motley Fool

"These products are safe when used correctly, but this will create some comfort and reassurance for children most vulnerable to some issues with these products," said Doug Petkus, a spokesman for Madison, New Jersey-based Wyeth, in a phone interview... Full Article at The Morning Call

In a statement released early Thursday, J&J (JNJ: , , ) said that its McNeil consumer-products division was recalling seven products intended to treat cough and colds in babies over reports that some parents, in rare instances, had misused the... Full Article at MarketWatch

WASHINGTON U.S. drug makers voluntarily pulled kids' cold medicines off the market on Thursday less than two weeks after the government warned of potential health risks to infants. Full Article at Globe and Mail

Major makers of over-the-counter infant cough and cold medicines announced today that they were voluntarily withdrawing their products from the market for fear that they could be misused by parents. Full Article at The New York Times

Products aimed at children under the age of 2 are being removed from store shelves due to "rare instantances of misuse" that could lead to accidental overdose, a trade group that represents over-the-counter drug makers said. Full Article at N.J. Courier-Post Online

Johnson & Johnson, Wyeth, Novartis and other drug makers voluntarily pulled some infant cold medicines off the market less than two weeks after the government warned of potential health risks. Full Article at CBS News